Inventor · disambiguated record
Nicole Alessandri-Haber
Also filed as: ALESSANDRI-HABER NICOLE · ALESSANDRI-HABER NICOLE M
8 granted patents·3 pending applications·4 citations·filing 2013–2024
77Inventor score
Files withREGENERON PHARMA11
Top patents by PatentIndex Score
11 records- 0180US11737435B2Non-human animals comprising a humanized coagulation factor 12 locusREGENERON PHARMA·Filed 2020·Granted Aug 29, 2023·1 cites·17 claims
- 0280US11470828B2Rodent model of mood disordersREGENERON PHARMA·Filed 2020·Granted Oct 18, 2022·1 cites·24 claims
- 0377US12201096B2Non-human animals comprising a humanized coagulation factor 12 locusREGENERON PHARMA·Filed 2023·Granted Jan 21, 2025·0 cites·16 claims
- 0472US9371383B2Anti-ASIC1 antibodies and uses thereofREGENERON PHARMA·Filed 2013·Granted Jun 21, 2016·1 cites·16 claims
- 0570US2023123787A1Rodent model of mood disordersREGENERON PHARMA·Filed 2022·Application pending·0 cites
- 0669US10072076B2Human antibodies to NAv1.7REGENERON PHARMA·Filed 2014·Granted Sep 11, 2018·1 cites·10 claims
- 0769US2025134920A1Treatment Of Myeloid Cell Dysfunction With Membrane Spanning 4-Domains A6A (MS4A6A) InhibitorsREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 0860US11464217B2Rodents having genetically modified sodium channels and methods of use thereofREGENERON PHARMA·Filed 2020·Granted Oct 11, 2022·0 cites·26 claims
- 0959US10513557B2Anti-ASIC1 antibodies and uses thereofREGENERON PHARMA·Filed 2017·Granted Dec 24, 2019·0 cites·27 claims
- 1057US9150648B2Anti-ASIC1 antibodies and uses thereofREGENERON PHARMA·Filed 2013·Granted Oct 6, 2015·0 cites·19 claims
- 1147US2016002332A1Anti-ASIC1 Antibodies and Uses ThereofREGENERON PHARMA·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Nicole Alessandri-Haber files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →